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ABSTRACT	
General anesthesia involves some targeting effects which aim to prevent the patient from suffering 
against the therapeutic aggression. These effects are hypnosis, analgesia, amnesia and immobility 
and to achieve them a combination of drugs is delivered into the patient, from which propofol and 
remifentanil are highlighted.  
In the operating room, monitoring systems are used to assess the depth of anesthesia in real time. 
This monitoring includes basic systems such as arterial blood pressure, oxygenation or 
electrocardiogram and electroencephalogram derived measures, which are more complex; from 
this last group, BIS index is a good indicator. Being able to predict the anesthetic depth from a set 
of input variables could be valuable during the surgery, as it would help the anesthesiologists to 
prevent adverse effects, and it would help the post-operative recovery. 
Knowing this, the aim of this project is to predict the probability to be in the optimal level of 
anesthesia, which is related to the BIS index. This probability is obtained from the input 
concentration of propofol and remifentanil, a hypnotic and an analgesic drug respectively, and from 
the demographic variables such as age, height or gender. To do so, a Logistic Regression model 
will be built with data from patients undergoing general anesthesia in Cirurgia Major Ambulatòria 
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General anesthesia is a drug-induced, reversible condition that includes behavioral and 
physiological endpoints, such as unconsciousness, amnesia, analgesia and immobility. These 
effects are induced by anesthetic drugs, highly powerful and with intense side effects such as 
respiratory depression, cardiovascular instability, altered control of internal temperature and others. 
The anesthesiologists must adopt measures to maintain physiologic functions inside normality 
range [1,2]. For instance, to avoid absence of respiration the anesthesiologist must introduce an 
endotracheal tube to connect the patient to a ventilation machine providing positive pressure 
ventilation [3]. 
Drugs used for general anesthesia produces distinct patterns on the electroencephalogram (EEG), 
from which we can highlight a progressive increase in low-frequency and a high-amplitude activity 
as the level of anesthesia intensifies [1]. The main characteristics of general anesthesia can be 
understood by comparing it with sleep and coma. Rapid-eye-movement (REM) sleep and non-REM 
sleep are the sleep cycles that human present; the EEG shows active high-frequency, low-
amplitude and high-amplitude, low frequency rhythms, respectively. On the other hand, coma is a 
state of profound unresponsiveness, resulting from a severe brain injury. EEG changes induced by 
general anesthesia are different from coma and from physiologic sleep. Some authors have defined 
general anesthesia as a reversible drug-induced coma state [1]. 
The following sections analyze the state of general anesthesia and its components, the drugs 
required to achieve general anesthesia and the different periods in which anesthesia is divided. 
1.1.1. Targeting	effects		
In the operating room, there a lot of surgical procedures conducted, and the anesthesiologists must 
generate a state of protection of the patient against the surgical aggression. To achieve that, a 
combination of some pharmacological effects is required. 
Hypnosis 
The hypnotic effect gradually starts with some degree of sedation that progresses to 
unconsciousness [5]. It can be achieved with different kind of drugs, a fact that supports the idea 
that related to unconsciousness different systems are controlling the same endpoint. 
Physiologically, it is referred as mind activity characterized by focused attention, dissociation and 
plastic imagination. During induction of unconsciousness, the patient feels general well-being, a 
sense of deep relaxation, eyelid heaviness and regular breathing that progressively loses its 
physiologic pattern, in order to concentrate on the internal environment and disconnect from 
external stimuli [6]. Several drugs produce hypnosis, from which γ–aminobutyric acid type A 
(GABA-A) receptor agonists can be highlighted. Propofol is classified into this group.  
 
After induction of anesthesia, the hypnotic effect must be evaluated to avoid it being excessive or 
insufficient. Once unconsciousness is achieved, some reflexes can no longer be used to assess it, 
especially when neuromuscular blocking agents are used. So, the most used way to assess the 
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Analgesia is referred as the loss or modulation of pain perception. Analgesia is an important effect 
to target during the surgical procedure since the intensity of noxious stimulation is very high and 
unbearable under normal conditions. The pain stimuli activate the µ, k and δ nociceptive receptors, 
[7] from where the pain pathways translating the noxious stimulation to the cortex are activated. 
One way to avoid it is by blocking these receptors by using opioids, such as remifentanil, fentanyl 
or alfentanil. 
The analgesia level cannot be directly measured, a problem that is more significant because of 
unconsciousness. There are commercially available monitors of antinociception, most of them are 
indirect systems based on the quantification of the variations in tonus of the sympathetic and 
parasympathetic activity. These monitors include physiological signals, such as heart rate, blood 
pressure, skin conductance, plethysmograph waveform, pupil diameter and EEG integrated-
signals. [5] 
Amnesia 
Amnesia is the memory suppression during surgery; this is, the impossibility of retain what has 
occurred since anesthetic state has started and for the whole surgical procedure. 
Immobility 
Immobility is described as absence of movement during the procedure, related or not to noxious 
stimulation [9]. Besides adequate analgesia, it can be achieved by the administration of 
neuromuscular blocking agents, also known as muscle relaxants, which block the connection 
between nerve and muscles at the endplate level. During the induction of anesthesia, they are 
mainly used to open the vocal chords and allow the introduction of the endotracheal tube. It might 
be required also during the course of surgery to facilitate surgical maneuvers [10]. 
Neuromuscular blockade can be obtained by using depolarizing drugs, such as succinylcholine, 
and non-depolarizing agents, such as rocuronium. Both of them have the aim to avoid the union of 
Acetylcholine (Ach) molecules to their postsynaptic receptors to generate the muscle contraction. 
While the firsts are acetylcholine agonists, the others compete with the Ach to occupy the receptors. 
[11] 
The degree of neuromuscular block can be measured with mechanomyography (MMG) and 
acceleromyography (AMG) preferably, because they measure the actual movement in muscles, 
but also with electromyography (EMG).  [5] 
1.1.2. Anesthetic	drugs	
Anesthetic agents can be classified in 5 main classes [4]: intravenous (IV) anesthetics, inhalational 
anesthetics, IV sedatives, synthetic opioids and neuromuscular blocking drugs. Anesthetics can be 
administered by inhalation but, an alternative method is injecting them exclusively through veins: 
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total intravenous anesthesia (TIVA). This method is seen as a good alternative to inhaled drugs, 
as patients who have TIVA has less nausea and vomiting, as well as a better recovery conditions 
after anesthesia. [5] However, further study is required to determine whether inhaled or intravenous 
drugs lead to better postoperative cognitive response. 
TIVA drugs can be administered either by manual techniques (intravenous bolus or constant 
continuous infusion) or by target-controlled infusion (TCI). TCI systems use predicted 
concentrations in plasma (Cp) or to the site of drug effect, also called biophase os effect-site (Ce), 
as the target controlled by the anesthesiologist. TCI systems use pharmacokinetic-
pharmacodynamic (PKPD) models to adjust, every ten seconds, drug infusion to achieve and 
maintain the target concentration selected by the anesthesiologist. TCI systems are used to deliver 
the hypnotic and the analgesic agents. The PKPD models are based on population studies 
correlating drug infusion to blood concentrations and effect by means of effect-site concentrations. 
[12]. Covariates such as weight, age or gender are used to individualize better the performance of 
the model and adjust the infusion rate to the characteristics of the patient [13]. 
The most common TIVA drugs are propofol, remifentanyl, fentanyl, alfentanil and sufentanil; 
ketamine is sometimes used but it has powerful effects on the brain such as hallucinations as well 
as a long duration of effects, delaying recovery. [14] 
Any combination of hypnotic and opioids can be used in TIVA but, the synergy between propofol 
and remifentanil for different clinically relevant endpoints is highly effective, and it achieves an 
adequate depth of anesthesia, considered as hypnosis and analgesia, and a rapid recovery [15]. 
While specific drug classes target specific clinical end-points, when they are combined, opioids 
also have sedative effects and propofol also has analgesic properties. [5] 
The following table includes some examples of the drugs that can be used and its classification 
[16]. In this section, the most common anesthetic drugs used in Cirugia Major Ambulatòria (CMA) 
of Hospital Clínic will be reviewed. 
Hypnotics Opioids Neuromuscular blockers 
Pentothal Morphine Succinylcholine (depolarizing)  
Etomidate Fentanyl Atracurium (non-depolarizing) 
Propofol Remifentanil Cis Atracurium (non-depolarizing) 
Ketamine Alfentanil Mivacurium (non-depolarizing) 
  Rocuronium (non-depolarizing) 
  Vecuronium (non-depolarizing) 





Propofol is a safe, effective, hypnotic, and amnesic anesthetic agent. [17] Its rapid administration 
produces vasodilatation and decrease of peripheric resistances, but these effects can be avoided 
if the perfusion is slow or continuous [18]. This drug can lead to respiratory depression, 
hypotension, decrease of oxygen consumption or decreased cardiac blood flow. At anesthetic 
doses the level of respiratory depression requires mechanical ventilation. It has an unspecific effect 
among lipid cell membranes and it acts as an allosteric modulator of GABAA receptors. It enhances 
de Cl- conductivity and the action of the GABA neurotransmitter, which inhibits the synaptic 
transmission through a hyperpolarization mechanism, opening the Cl- channels. As it is highly 
lipophilic, it can reach quickly the central nervous system (CNS), leading to the hypnotic effect. [17] 
It is known for its rapid onset of action, its rapid recovery time and its little post-anesthetic sedation 
and sequalae. Nonetheless, due to its lipidic component and related also to the diameter of the 
vein in which it is injected it can produce a stinging feeling at injection, which in some cases could 
be avoided with the administration of lidocaine. Despite this, it is an excellent drug for the 
ambulatory surgical setting. 
Remifentanil 
Remifentanil is a synthetic opioid whose main goal is to provide the analgesia [19]. It is a µ- agonist, 
with low affinity to κ, σ, δ receptors and produces bradycardia and hypotension. Furthermore, it has 
a synergistic effect with other hypnotic agents delivered intravenously, and enhances the loss of 
consciousness. As it is an opioid, it can produce a respiratory depression, when used for general 
anesthesia, mechanical ventilation will be required and, as in the case of propofol, patency of the 
airway must be achieved by either the placement of a laryngeal mask airway (LMA) or through 
laryngoscopy and  
Its main advantage is its short half-life and rapid clearance, due to the metabolism by unspecific 
plasmatic and tissue esterases. [20] 
Rocuronium 
Rocuronium is a non-depolarizing neuromuscular blocker, used to produce muscle relaxation and 
immobility during surgery. Its use facilitates airway management, and the ability to ventilate and 
oxygenate the patient. As with many other drugs there are very few cases reported of allergic 
reactions including anaphylaxis [21]. Its main advantage among other blockers is its rapid acting 
and its reversibility by anticholinesterase drugs or the specific reversal agent sugammadex [22] 
It is not metabolized into active metabolites and it has a low lipid solubility, so it cannot pass lipid 
membrane barriers, such as the blood-brain barrier as the previous drugs. Hypothermia, 




When anesthesia appeared, the only way of assessing the patient’s depth of anesthesia was by 
physical examination. It was not until 1937 when a monitoring approach appeared; it was developed 
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by Dr. Arthur Guedel and it consisted on 4 stages [23]: analgesia or disorientation, excitement or 
delirium, surgical anesthesia and overdose [24]. The first stage takes place at the preoperative 
anesthesiology holding area, with patients sedated but conversational and conscious, and the 
delirium phase includes disinhibition, uncontrolled movements, loss of eyelash reflex, hypertension 
and tachycardia but with the presence of airway reflexes. Then, the surgical anesthesia is the 
targeted anesthetic level in general anesthesia, where ceased eye movements and respiratory 
depression are highlighted. Finally, overdose occurs, proportional to the amount of surgical 
stimulation, which leads to severe brain or medullary depression; it goes from respiratory cessation 
to potential death.  
Although this classification is still used, due to the arrival of newer anesthetic medications, delivery 
techniques and monitoring technologies, the stages described by Guedel are not used. General 
anesthesia is considered as a continuum that can be adapted to the specific responses of the 
patient by modulating anesthetic drug administration and concomitant drugs depending on the 
expected changes due to the surgical process or to the specific responses of the individual patient. 
For better description, general anesthesia can be divided in 3 other periods: [1] 
Induction period  
This period begins with the injection of hypnotic drugs, such as propofol, with which sedation is 
induced. The patient goes from a calm state to unconsciousness although sometimes a slight 
paradoxical excitation appears. Loss of verbal response to commands is evident. At the same time, 
opioid administration starts to obtain adequate analgesia to block noxious stimulation during airway 
management maneouvers. Absence of spontaneous breathing and intense decrease in values of 
processed EEG parameters indicate that the brain is losing its normal function patterns due to 
general anesthesia. When more hypnotic and opioid agents being injected, the respiratory pattern 
becomes irregular and breathing must be supported with manual ventilation and face mask. When 
adequate hypnotic level and enough analgesia has been achieved, airway should be warranted to 
allow respiratory function and oxygen administration. This means that either a laryngeal mask or 
endotracheal tube must be placed. The latter will require a neuromuscular blocking agent. 
Maintenance period 
During this phase, a combination of hypnotic agents (inhalational or intravenous) and opioids, 
sometimes with added neuromuscular blocking agents, maintains general anesthesia. 
Hemodynamic support is often required by means of sympathomimetic drugs. Ventilatory and 
thermoregulatory support are also required. Besides basic and advanced monitoring technologies, 
there are many indicators which evaluate the state of anesthesia, such as the EEG to control the 
hypnotic component and others to control response to nociceptive stimulation (changes in pupil 
size, heart rate variability, sympathetic activity indicators and also EEG changes…). The changes 





Emergence and recovery from general anesthesia starts when anesthetic delivery stop. The patient 
gradually recovers protective reflexes such as coughing and ability to breath followed by opening 
the eyes and sluggish response to commands. It is a passive period that depends on the patient 
metabolizing and eliminating anesthetic drugs remaining in the body, the physiology of the patient 
and the duration of the surgery [25]. During this period, a normal pattern of spontaneous ventilation 
is recovered with adequate respiratory rate and tidal volume, and salivation, tearing and responses 
to painful stimulation begin. Recovery of breathing means removal of laryngeal mask or extubation. 
Once stable physiologic patterns are observed, the patient is taken from the operating room to the 
post anesthesia care unit until everything comes back to normal physiological ranges. 
1.2. Anesthesia monitoring 
The clinical observation and evaluation by the anesthesiologists are essential to ensure the safety 
of the patient during the anesthesia. Thus, anesthesia monitoring is a key aspect to be achieved. 
Due to its importance, monitoring systems are one of the areas that have evolved more during the 
recent years. 
The main objective of monitoring is to observe and to register the temporal evolution of the basic 
physiologic variables during the different stages of anesthesia and surgery. The equipment must 
be evaluated prior to the intervention [26]. It is highly recommended to check the oxygenation, 
ventilation, cardiovascular function, temperature, neuromuscular blocking level and depth of 
anesthesia [27]. However, the patient must receive a direct vigilance by the anesthesiologist. 
Anesthesia monitoring technology can be divided into two groups: basic and advanced monitoring. 
1.2.1. Basic monitoring systems 
Basic monitoring systems are those which are essential to control vital signs. 
1.2.1.1. Pulseoximeter 
During the anesthesia, it is required a quantitative monitoring of the oxygen saturation in arterial 
blood; to do so, a pulseoximeter is used. It is a non-invasive method, based on the placement of a 
sensor on the fingertip. Light of two different wavelengths passes through the finger of the patient 
from the emitter to a photodetector and the change of absorbance of each of the wavelengths is 
measured. Apart from providing the blood oxygen saturation, it can provide indirect data from the 
cardiovascular state of the patient as well as measuring different variants of hemoglobin levels like 
carboxyhemoglobin or methemoglobin. 
1.2.1.2. Electrocardiogram 
The electrocardiogram (ECG) analysis is a way to analyze the cardiovascular function of the 
patient. It displays the electrical signal coming from the heart and the output parameters are the 
heart rate, the heart rhythm, conduction, repolarization and asystole. These parameters can give 
us some insight about the heart rhythm, ischemia and an indirect estimation of the autonomic 
response to stimulation. The number of R pikes per time gives an estimate of heart rate and the 
ST segments provides information about the absence of O2 arriving to the myocardium and the 
induction of ischemia. It is advisable to register the 5 derivations [32]. 
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1.2.1.3. Arterial blood pressure 
Arterial blood pressure is another method of monitoring the cardiovascular function. It is an indicator 
of the pressure exerted by blood flow on arterial walls, and the measurements are obtained 
periodically. If the blood pression is out of an established range, it is alarming and can be 
physiologically important [28]. This can be measured either by a non-invasive form with an inflatable 
blood pressure cuff or invasively with catheters placed inside a peripheral artery such as radial [29]. 
1.2.1.4. Capnography 
Capnography gives information about the ventilatory function. It is the monitoring of the 
concentration of partial pressure of carbon dioxide (CO2) in the respiratory gases.  
During anesthesia, it is useful to confirm, by the CO2 detection, the endotracheal intubation and to 
ensure a good communication between the anesthetic circuitry and the respiratory tract, to evaluate 
the ventilation and pulmonary perfusion and to detect cardiac output alterations and pulmonary 
embolism. [27] 
1.2.2. Advanced monitoring systems 
There are other advanced systems that allow clinicians to explore in deeper detail the function of 
organs that are not vital or are vital in a different sense. They are mostly used for surgeries where 
it is advanced that a complex management of the patient can occur such as cardiovascular 
procedures, neurosurgery or in the the critical care setting for postoperative management. 
1.2.2.1. Electroencephalogram  
Nowadays, the EEG is the most used advanced monitoring system. It measures the effect of 
anesthetics in individual patients and allows to monitor the effects induced by the doses of 
anesthetic drugs that are being administered. The EEG allows to observe the changes in 
brainwaves due to the anesthetic effects. The EEG signal is 100 times smaller than the 
electroencephalogram (ECG) signal, so the artifacts on the EEG can contaminate the tracing of the 
waves. 
This technique registers the electric activity generated by the layer of pyramidal neurons in the 
cerebral cortex. In order to record this activity, generated by the movement of ions, some electrodes 
are put on the scalp surface of the patient, so it is a non-invasive method. These electrodes should 
optimally have an impedance to the electric signal, which ranges from 0.3-5 kΩ [35] with the 
objective of refusing the artifacts and processing only the correct information. Once the scalp has 
been conveniently cleaned, the electrodes are placed and the EEG signal is visualized in a monitor.  
During anesthesia, each EEG waveform is associated with a different anesthetic state. Figure 1 
shows the raw, unprocessed, EEG tracing of a patient under the effects of the hypnotic propofol, 
transitioning from awake to unconsciousness, passing through paradoxical excitation and sedative 
state. We can observe how at the beginning, in a basal state, low amplitude and high frequency 
pattern dominates, but as the drug is administered, it changes to high amplitude and low frequency 
waves. During deep anesthesia, a “burst-suppression” pattern predominates. At this point, high-
frequency and large amplitude waves (bursts) are present, alternating with period of absence of 




Figure 1: Effect of propofol in the EEG unprocessed signal. From an awake to an unconscious 
state. 
However, interpreting this time domain analysis of the EEG in the operation room is challenging. 
So, a spectral analysis is computed by the spectrum, which decomposed a given segment of 
electroencephalogram data in different segments to derive its frequency components through Fast 
Fourier Transform (FFT) methods [32]. From here, brainwaves are classified by their characterizing 
frequencies in four main types, depicted in Table 2 Changes in power in these bands can be 
identified with changes in the brain’s anesthetic state.  
Wave Frequency (Hz) Clinical meaning 
β 13-25 Conscious, awake, alert state 
α 9-12 Relaxed, calm, lucid state 
θ 5-8 Deeply relaxed 
δ 1-4 Deep sleep  
Table 2: Brainwaves derived from the spectral analysis [33] 
As mentioned previously, using raw EEG to measure the depth of anesthesia is difficult because 
of the effort and training required to interpret such a complex signal. In order to extract from the 
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complex EEG signal the information only relevant to anesthetic drug effects, different monitors have 
been commercialized based on the application of different methods of signal analysis. The 
Bispectral Index (BIS) is one of the most used parameters and the one with more clinical work 
supporting its use. Although its algorithm is not public, the value of the BIS changes over time 
according to the proportions of high vs low frequency component of the EEG signal. It is a 
dimensionless number ranging from 99, meaning normal awake activity, to 0, which refers to 
absence of electrical activity in the cortex. [34] 
In order to calculate the BIS value, a sensor with four electrodes is placed in the forehead of the 
patient, according to a predefined position, and the value displayed in the monitor corresponds to 
a degree of hypnotic effect. The different BIS ranges with their meaning are shown in the table 
below. [35]  
BIS range Degree of sedation 
100-90 The patient is awake and shows response to verbal stimulation. 
80-70 The patient responds to loud commands or mild shakings. Below this level, 
mechanical ventilation is required. 
70-60 There is still a response but due to intense tactile stimulation. 
60-40 General anesthesia. The patient is not able to respond to verbal stimulus. 
<40 Hypnotic state. 
<20 Burst suppression. At this stage, the patient shows a limited respiratory drive. 
0 Totally suppressed EEG. 
Table 3: BIS ranges and its degree of sedation. 
1.3. Predictive	modelling	
Predicting analysis consists on extracting information from existing data and using it to predict 
trends and behavior patterns, to apply them to predict new events [36]. This is achieved by finding 
relationships between the variables of the initial data and, by an iterative process, deriving an 
algorithm to create a model with the ability of predicting future events. However, how well the 
predictive model is generated depends on the way it has been computed. The pre-processing and 
the amount of data is a key factor to consider just before the modelling stage. 
This can be directly related with Machine Learning (ML); it is the field of study through which 
computers learn without being explicitly programmed [37]. Machine Learning is one of the branches 
of Artificial Intelligence (AI). Depending on how the algorithm has been created, we distinguish two 
main classes of Machine Learning approaches: [37,38] 
- Supervised Learning: This approach uses labeled datasets; these datasets train the 
algorithm. As the output label is known, the model can measure the accuracy and learn 
over time, to achieve the expected output. Two problems are derived from this category: 
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o Classification problems: The algorithm assign new events into a specific category. 
They are used to predict discrete values. 
o Regression problems: The algorithm is used to understand the relationship 
between dependent and independent variables. They are used to predict 
continues values. 
- Unsupervised Learning: These kinds of algorithms learn by their own, from observing 
patterns in the input data. The unlabeled input data is divided into different clusters. 
1.3.1. Logistic regression  
Logistic regression is a technique borrowed by ML from the field of statistics, and based on 
supervised learning. It is used for binary classification problems, which aim to estimate the 
relationship between a dependent variable and a set of independent variables [39].  The dependent 
variable is binomial and it takes values of 1 (event, with probability p) and 0 (no event, with 
probability 1-p). This method calculates the probability that the realization of the output variable 
belongs to the appropriate category, based on observation of input variables. Moreover, the model 
equation is an exponential function, which can be transformed to a linear function if a logarithmic 
transformation is applied. 
The main objective of a logistic regression is to model the influence of some variables in the 
occurrence of an event and to study which factors contribute to it and which ones are negligible 
[39].  
This model uses a sigmoid function as a cost function, which is depicted in Figure 2. The domain 
of the sigmoid function is limited between 0 and 1, so it is suitable for classification methods; the 
predicted output lies within this range. 
 
Figure 2: Sigmoid function. 
Logistic regression models the probability of an outcome based on individual characteristics. As 






1 − p) = β. + β0x0 + β2x2 + ⋯+β4β4 
Equation 1: Multivariate logistic regression model equation. 
where p is the probability that an event occurs, β5 are the estimators of the regression coefficients 
(predicted weights or coefficients), x5 are the independent variables or risk factors and β. is the 
intercept, which is the expected mean value of f(x) when all x5 are 0.  
In the case of a simple logistic regression, the equation above is reduced to: 
f(x) = log	(
p(x)
1 − p(x)) = β. + β0x0 
Equation 2: Simple logistic regression model equation. 
If the cost function is applied to Equation 2, the logistic regression function, representing the 
probability for an event to occur, is obtained: [41] 
p(x) = log	( 0
0789(:;<:=>=<:?>?<⋯<:@:@)
)   p(x) = log	( 0
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) 
Equation 3, 4: Probabilities of occurrence in multivariate and simple logistic regressions models, 
respectively. 
The model is trained to get the unknown parameters β which predict better the output. To do so, 
the maximum likelihood estimation is used; this method maximizes the log-likelihood function (LLF) 
for all observations: 
LLF =C(y5 logEp(x5)F + (1 − y5)log	(1 − p(x5))) 
Equation 5: Log-likelihood function to obtain the best coefficients for the model. 
Once the probability p(x5) for a given input x5 is defined, the classification is proceeded. The input 
will be classified as 0 or 1 depending on the probability threshold; by default, 0.5 is taken. 
1.3.2. Model evaluation 
When building a model, apart from training and testing it with different groups of data, its 
performance has to be evaluated. This evaluation is done with the test set because if it was done 
with the training set, the model would be overfit. This overfitting would be consequence of a correct 
prediction of all the labels, as the model would remember the data with which it had been trained. 
In classification problems, there are some well-known metrics to evaluate it [42]: 
- Classification Accuracy 
The accuracy consists on the ratio between the correct predictions and the total predictions. The 




- Confusion matrix 
The confusion matrix is a NxN table, where N is the number of classes, that contains more detailed 
information about the correct and the incorrect types of predictions. This is a more accurate metrics 
than the accuracy. The diagonal of the confusion matrix contains the true predictions, while the 
numbers out of the diagonal represent the classifier mislabels. So, it is interesting to have high 
numbers on the diagonal, because it indicates a correct performance of the model. Figure 3 shows 
how a confusion matrix is built. 
 
Figure 3: Confusion matrix scheme for a 2-classes classification problem. 
As shown in Figure 3, the confusion matrix returns 4 values: 
- True Positive (TP): The model predicts a positive label, and the real value is positive. 
- True Negative (TN): The model predicts a negative label, and the real value is negative. 
- False Positive (FP): The model predicts a positive label, and the real value is negative. 
(Type 1 error) 
- False Negative (FN): The model predicts a negative label, and the real value is positive. 
(Type II error) 
From these parameters, apart from the accuracy introduced before, some other evaluation metrics 
can be obtained.  
Accuracy = 	 LM7LN
LM7LN7OM7ON
			Precision = 	 LM
LM7OM
				Sensitivity = 	 LM
LM7ON
  
Equation 6,7,8: Accuracy, precision and recall expressions 
 
Specificity = 	 LN
LN7OM
 F1 − score = 	 2·MW8X5Y5Z[·\8X]^^
MW8X5Y5Z[7\8X]^^
 




- Area under the receiver operating characteristic (ROC) curve (AUC-ROC) 
The AUC-ROC is one of the most widely used metrics for performance evaluation. It summarizes 
the overall accuracy of the model. It is a graph which shows the performance of the model 
throughout all the classifiers thresholds. This curve is created by representing two parameters: true 
positive rate (TPR or sensitivity) versus false negative rate (FPR or 1-specificity). The different 
points of the curves correspond to the different cutpoints used to determine whether the test results 
are positive [43]. Figure 4 shows how the ROC curve is plotted.  
 
Figure 4: ROC curve plot 
Although all of these metrics are used to measure the performance of the classifier, their use to 
evaluate the performance will depend on the objectives of the project. All of them evaluate the 
classifier for a particular range while the ROC curve includes all the range of decision thresholds 
from a diagnostic test [43]. 
The AUC-ROC can take values between 0 and 1; 0 indicates perfectly inaccurate test and 1 reflects 
a perfectly accurate test. Between them, an AUC of 0.7-0.8 is acceptable, 0.8-0.9 is excellent and 







General anesthesia is defined as the combination of loss of consciousness and inability to perceive 
painful stimulation due to the administration of anesthetic drugs. [44] Evaluating depth on 
anesthesia, either the hypnotic effect, referred to the loss of consciousness, and the analgesic 
effect, referred to the loss of pain perception, requires monitoring. This section will introduce the 
main parameters used to monitor both states. 
If we first focus on the hypnotic effect, nowadays anesthesiologists use different approaches; an 
example could be clinical signs during the induction stage, such as the absence of response to 
verbal command or loss of palpebral reflex.  
These clinical signs are not continuous. That is why the EEG is also used to measure the depth of 
the hypnotic effect. Although understanding the raw EEG is challenging, there are some monitors 
which process the data coming from it and give as an output a parameter which can be clinically 
interpretable by the anesthesiologist. The most important EEG monitoring methods are: the EEG 
spectrum frequency, the bispectral analysis (see section 1.1.2), EEG entropy and the evoked 
potentials (visual, sensorial or auditory). [44] While the first three monitors are passive, based in 
spontaneous signals coming from the EEG, the last ones are active and measure the response to 
a stimulation state.  
In order to proceed with the spectrum frequency analysis, an EEG-Fourier Transform has to be 
done; as the hypnotic drugs’ effect increase, the EEG activity decreases. Among all of the evoked 
potentials, the auditory evoked potentials (AEP) are the most affected by the hypnotic drugs. They 
are calculated by applying repeatedly an auditory stimulus to the patient and analyzing a period of 
100 ms after the stimulation, just when the anesthetic drugs can have more incidence on them. [45] 
As it has been introduced at the beginning of the section, the analgesic state is another key stage 
to analyze during the monitorization of the depth of anesthesia. The first physiological response to 
nociceptive stimulus is an activation of the autonomic neural and hormonal pathways [46]. Although 
there is not an objective measure of the analgesic state, some parameters are nowadays used to 
generate the nociceptive monitoring monitors. Vital signs are used, such as the arterial blood 
pressure, heart rate, sweat or tears (known as PRST) or the absence of movement [44]. Moreover, 
the heart rate (HR), specifically a reduction of the heart rate variability power in the high frequency 
band (HRV-HF), derived from the electrocardiogram [47], or a reduction in the photo-
pletysmographic waveform amplitude (PA) are used. Moreover, electro galvanic skin properties are 
considered to evaluate responses to pain, which measure changes in skin conductance or number 







Once introduced the different parameters used to monitor the depth of anesthesia, this section will 
introduce the commercially available monitors to evaluate it. The way to proceed will be the same 
as in the previous section. First of all, the hypnotic monitors will be introduced. Then, the analgesia 
monitors will be reviewed. 
3.1.1. Hypnosis monitors 
Some monitors which aim to evaluate the hypnotic effect during anesthesia are presented below 
[45]. All of them are derived from the EEG signal. 
- BIS monitor (Aspect Medical Systems): Its main component is the bispectral analysis, 
which evaluates the phase relations from a single channel of EEG signal. The output is the 
BIS index (explained in section 1.2.2). The BIS algorithm is unknown but it is constantly 
updated. This monitor, as all EEG measurement systems, is altered by artefacts, such as 
the electrocardiogram, eye movement and power grid interferences, which have to be 
removed using different filtering methods prior to the algorithm calculation. 
- Narcotrend monitor (MonitorTechnik): This monitor classifies anesthesia into five stages 
(A-F), each one subdivided in three sub-stages. The parameters of the algorithm are 
extracted from the analysis of the frequency interval between 0.5 and 47 Hz and the output 
ranges between 0 and 100. 
- Patient State Index (PSI, Masimo): It calculates the output PSI (patient state index) value 
from four EEG channels and features from the 0-50 Hz and the specific frequency bands 
are calculated. The PSI is also a 0-100 range dimensionless number. 
- qCON monitor (Quantium Medical) [48]: In this case, qCON is obtained from a single EEG 
channel, and after eliminating artefacts and processing the signal using spectrum analysis. 
An Adaptative Neuro Fuzzy Interference System (ANFIS) trains a model to generate the 
output value. The output is the qCON index, which ranges between 0 and 99; high values 
of this index represent an awake state while low values indicate absence of brain activity. 
During anesthesia, a value between 40 and 60 is recommended. 
 
3.1.2. Analgesia	monitors		
In the case of analgesia, the commercialized monitors detect one or two parameters: [49] 
- Analgesia Nociception Index (ANI): It is a dimensionless index which ranges between 0-
100, calculated from the area under the curve of the high-frequency spectrum of the HRV. 
Higher values of ANI are related with less stress and less pain, as they represent higher 
parasympathetic activity. 
- Nociception level index (NOL): It is a multiparameter nociception monitor, as the algorithm 
comes from photoplethysmography, galvanic skin response, temperature and 
accelerometer. It is dimensionless and goes between 0 and 100. During general 
anesthesia, values between 10 and 25 are advisable. 
- qNOX (Quantium Medical): This index takes values between 0 and 99 and, as qCON, it is 
modelled using ANFIS. Its aim is providing information about the probability of movement 
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when a noxious stimulus is applied. A qNOX value above 60 represents a high probability 




























Monitoring the depth of anesthesia is an important factor in the operating rooms. This passes 
through being able to determine whether the anesthetic agents are being administered properly to 
maintain a good level of anesthesia. On contrary, underdosage or overdosage would lead to an 
intraoperative awareness with recall or to a prolonged recovery time with postoperative 
complications, respectively [45].  
Moreover, as it has been reviewed previously, either the dose of propofol an remifentanil induces 
changes in the body which are translated in a level of depth of anesthesia. So, generating a model 
with the ability to predict whether new drug concentrations would lead to an acceptable depth of 
anesthesia would help anesthesiologists to predict adverse events. 
First of all, among all the different monitors introduced in section 2.2, the BIS has been chosen as 
the output to train and fit the model. However, the goal of this project is not exactly monitoring the 
depth of anesthesia in real time but being able to predict this state, from a given parameters such 
as propofol or remifentanil doses in terms of BIS index.  
When thinking about the possibilities to generate the model, different approaches came to my mind, 
all of them related with ML algorithms. Different possibilities such as Deep Learning (DL) 
techniques and Logistic Regression methods were evaluated. DL is a branch of ML which works 
with neuronal networks, with highly connected input and output nodes. Due to the over-
parameterized black-box nature, it is difficult to interpret the prediction results. [50] Nonetheless, 
as it will be explained later on, as the available data can be processed to obtain binary input 
variables, Logistic Regression appeared to be a good option to generate the model. 
Another important aspect to consider is the software used to implement the model. RStudio, 
MATLAB and Python were the different possibilities. They are programming languages which offer 
some libraries to build a logistic regression model and they are compatible with the given data, so 
any of them would be suitable. But, when choosing between one of them, the most important factor 
I considered was the previous experience. Although they have been introduced to me during the 
previous courses, Python is the option with which I am most familiarized and, from my point of view, 
the most intuitive one. 
At the end, the proposed solution to proceed with the implementation of the model was using a 









Once the different possibilities have been considered and the logistic regression method has been 
chosen, it has to be implemented.  
In order to understand the methodology followed, depicted in Figure 5, the objective of the project 
is introduced. As mentioned in sections above, the aim of this study is to calculate the probability 
to be in an optimal level of depth of anesthesia derived from an input concentration of drugs. This 
depth of anesthesia is obtained from the BIS index, and we will consider that the optimal range 
comprises values between 45 and 55. So, the logistic regression will be applied between the input 
drug concentration and the corresponding BIS. However, to make the modelling step easier and 
more interpretable, there is an intermediate step which includes transforming the drug 
concentration to a predicted BIS value, generated with the propofol’s Schnider model, which will be 
explained later on. At the end, the data of the model will be the predicted BIS value, as independent 
variable, and the binomial real BIS index, obtained from the patients, as the dependent variable. 
Once this first model is generated, some covariables such as remifentanil concentrations or 
demographic variables (age, weight, height) are added in order to study their influence in the 
predictions. 
 
Figure 5: Workflow followed during the development of the model building. 
All models are built from a set of available data; the first step was familiarizing with it. This consisted 
in a stay at CMA acquiring data from patients undergoing general anesthesia, and it lasted one 
month approximately. After being familiarized with the surgical environment and with the machines 
from the tower of control of anesthesia, it came the model building stage. But the initial data had to 
suffer some preprocessing steps before using it to train the model.  
The next step was building the model. The data had to be separated into two groups: training and 
test. Once the model was trained with the first subgroup, and the proper parameters of the model 
were obtained, it had to be validated with the test group. Ideally, after validating the model with the 
test data, a prospective validation would have to be proceeded, with data collected after building 
the model. However, due to the lack of time this step is out of scope. Finally, interpretation of the 
results was carried out. 
Taking this into account, the methodological part of my project consisted of three main parts. The 
first one was the data collection, then the preprocessing of the data was proceeded in order to 




In order to proceed with the modelling, the first thing needed is the data. The data belongs to the 
SPEC-M (Systems Pharmacology Effect Control & Modelling) Anesthesiology department of 
Hospital Clinic of Barcelona. Specifically, it is collected from patients who undergo surgery with 
general anesthesia in the operating room number 4, carried out by Dr. Gambús. These surgeries 
are all related with gynecologic and obstetrics procedures including laparoscopy, among others; 
thus, all the population of the study is formed by women.  
The data has been recorded under the authorization of the Ethics and Clinical Research 
Commmittee (CEIC) of Hospital Clinic of Barcelona (Ref nº 2013/8356). My stay at CMA collecting 
data took place between February, 2021 and April, 2021. However, the database is highly 
extensive, as recordings from patients began in 2013; nowadays, it is fed with more than 1500 
patients.  
Moreover, one important fact to consider is that the anesthetic agent is administered by TIVA 
techniques (see section 1.1.2). As introduced above, the main drugs delivered to the patients in 
this surgical room are mostly propofol, remifentanil and rocuronium and the administering follows 
the same pattern in almost of all the patients. Firstly, propofol is administered by the infusion pump 
TCI-TIVA, with doses between 2-2.5 mg/kg and once the hypnotic effect is achieved, remifentanil 
is delivered to generate analgesia. Its initial dose is 1 mg/kg and it involves the placement of LMA 
or tracheal intubation, as explained at the beginning. This leads to the administering of rocuronium 
to block the musculature and immobilize the patient (usually a 30 mg dose). During surgery, other 
drugs can be administered to maintain the patient’s constants stable: atropine (if bradycardia 
occurs) and ephedrine or urapidil (if hypotension). 
The Anesthesiology control tower of SPEC-M research group in Hospital Clinic is depicted below. 
It consists of three monitoring devices (BIS VISTA, Conox and Drägger Infinity Gamma), the TCI-
TIVA system and a computer where the data is stored. The data is acquired every 1 second and it 
is stored in a computer; each patient is saved in a different file. The different events occurred during 
surgery such as the loss of verbal or palpebral response, the corneal reflex, intubation and 
extubating during mechanical ventilation or infusion of ephedrine or atropine are recorded with the 




Figure 6: On the left, anesthesiology control tower, with the monitoring devices and the TCI 
infusion pump. On the right, the remote control used to collect data. 
Data from BIS VISTA, Drager Infinity Gamma and TCI-TIVA is computed with Rugloop II® software. 
In addition, this software allows to write down the different events that take place during surgery, 
obtained from pressing the remote-control buttons. Then, Conox® collects data separately and 
both softwares are then synchronized to obtain the recordings in the same file. 
The different monitoring machines comprising the control tower, with the data obtained from each 
one, are descripted in the table below [51-53]: 
Monitor (commercial 
company) Description Parameters 
BIS VISTATM (Aspect 
Medical Systems)  
It monitors the hypnotic state of the 
brain, from the acquisition and 
processing of EEG signals. Four 
electrodes are placed on the 
patient’s forehead to acquire them. 
SystTimeBIS 
BIS (Bispectral index) 
EMGBIS (Electromiogram index) 
BBSBIS (Burst Supression index) 
SQI09 (Signal Quality Indicator) 
Infinity® Gamma 
(Dräger) 
It is a compact vital signs 
(hemodynamic) monitor. It provides 
information about ECG, 
respiration, pulseoximetry (SpO2), 
temperature and blood pressure. 
HR (Heart Rate) 
NIBPsys (systolic blood pressure) 
NIBPdia (diastolic blood pressure) 
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Three electrodes are placed in the 
patient’s chest to measure ECG 
derived parameters. 
NIBPmean (mean blood pressure) 
RespiRate (Respiratory Rate) 








It allows anesthetics to achieve a 
stable plasma or estimated effect-
site concentration of propofol or 
Remifentanil. The drug is 
automatically delivered through a 
radial venous. The system 
calculates the infusion rate in order 
to maintain the predefined target 
concentration. To do so, 
demographic parameters from the 
patient are considered. 
CpREMI – CpPROP (Plasmatic 
concentration) 
CeREMI – CePROP (Effect-site 
concentration) 
InfVolREMI – InfVolPROP (Infusied 
volum) 








This non-invasive monitor collects 
information about the hypnotic and 
the analgesic effect, through qCON 
and qNOX indexes, respectively 
(see section 2.2). To do so, it uses 
three electrodes placed in the 
forehead, together with the BIS 
electrodes. 
qCON (hypnotic effect index) 
qCONEMG (Electromiogram index) 
qCONBS (Burst Supression index) 
qCONSQI (Signal Quality Indicator) 
qCONqNOX (analgesic effect index) 
qCONZref 
qCONZpos 
0-127 Hz (EEG spectrum at each 
frequency) 
Table 4: Monitoring systems and parameters obtained from the control tower of anesthesiology. 
The resulting files are Excel documents with different columns, one for each parameter introduced 
in the table above. Apart from these columns, three parameters are added: an ID patient column, 
a Time column (in seconds) and an Events column.  Moreover, each row represents one second 




After two months collecting data to feed the database, and once being familiarized with the 
anesthesia environment in the operating room, it comes the moment to start the modelling step. 
But, the data used to build the model is not that which I collected during my stay at CMA because 
at the beginning of the modelling stage I was simultaneously acquiring data in the control tower 
and training the model. 
So, the data I used was already available from 85 prior patients with ID numbers between 568 and 
665; thus, 85 excel files are the initial raw data of the project. Before proceeding with the modelling 
step, this data has to be processed in order to eliminate the unneeded columns and rows and to 
dichotomize the variables to prepare it for the Logistic Regression model.  
This preprocessing is generated using two libraries from the Python program: pandas and numpy. 
Both of them are used as data analysis and manipulation tools. Furthermore, an available Schnider 
pharmacokinetic pharmacodynamic (PKPD) propofol model built with Monolix software is used to 
generate the BIS predictions from these patients. 
First of all, the prediction of BIS is carried out. The Schnider model considers two compartments 
and an inhibitory effect among BIS. These two compartments are the central (plasmatic) and the 
effect compartment (effect-site). From the propofol infusion rate, the plasmatic concentration is 
calculated by Schnider model. Then, following a first order equation (Eq. 11) with a first-order rate 
constant Ke, the effect-site concentration is obtained.  
dCe
dt = Ke ∗ (Cp − Ce) 
Equation 11: First order equation to obtain Ce from Cp 
And finally, the BIS prediction is obtained from Equation 12, 
BISeW8f5Xg8f = 100 ∗ i1 −	
Cej
Ce50j +	Cejl + 	e 
Equation 12:  BIS prediction expression, derived from Ce  
where Ce50 is the Ce associated with 50% of the maximum effect and e is the residual error, 
considered fix. The BIS inhibitory effect is introduced by Ce50 and γ, which is the steepness of the 
concentration versus the response relation and adds a sigmoid shape to this effect.  
This prediction step has been run by Dr. Jaramillo because he has access to this Monolix model. 
In order to reduce the time to predict the BIS index, the initial data is reduced and the data passed 
to the Schnider model is 10 times smaller. Instead of predicting the BIS at every second, one row 
each ten is selected. Moreover, all the data is put in a single file to use it in Monolix. 
The results of the parameters obtained with the model are shown in the table below, with no 







Ke_pop 0.13 0.0011 0.854 
Ce50_pop 2.25 0.0063 0.279 
gamma_pop 1.46 0.01 0.692 
Error Model Parameters 
e 12.91 0.048 0.369 
Table 5: Parameters of the PKPD propofol-BIS model. Estimated standard error (S.E) and 
Relative Standar Error (R.S.E.) for each parameter are shown in the table. 
The “predictions vs observations” plot can be seen in Figure 7. As it is depicted, the error between 
them is not so high. They follow the ideal theoretical line represented in black, with some deviation. 
This deviation corresponds to the standard error, e, of the model, which is ±12.91.  
 
Figure 7: Prediction vs observations plot. 
Figure 8 shows some examples of the real BIS and the predicted BIS. In these graphs, it can be 





Figure 8: Individual predictions for some individuals. 
Once the BIS predictions are generated, the preprocessing step has to be followed. To generate 
the main model, two sub-models are created. Due to the sigmoid shape of the Logistic Regression, 
the model cannot be built with the whole data. That is why 0-50 and 50-100 subgroups are obtained 
from the predicted BIS value. As the optimal range comprises very few values (10 values) from the 
total BIS range (100 values), this division is also made to improve the accuracy of the model.  
First of all, a rearrangement of the file with which I work takes place. From all the initial columns 
introduced in Table 4, only a few of them are needed: 
- BIS: recorded BIS. This column is binarized as: 
o BIS_up_45: All the BIS values above 45 are set to 1. Values from 0 to 45 are 
transformed into 0.  
o BIS_down_55: All the BIS values below 55 are set to 1. Values from 55 to 100 are 
transformed into 0. 
- Pred_BIS: the BIS predicted by the propofol model. 
- Pred_BIS_disc: PRED_BIS column dichotomized in order to obtain a 0 when Pred_BIS<50 
(model A) and a 1 when Pred_BIS>50 (model B). This is only done to divide the data into 
two files, to generate each sub model.  
This file will be used in the next section to build the first model, which only considers the effect of 
propofol.  
When studying the effect introduced by the covariables, two more files are created which include 
the Ce_Remi column when the effect of Remifentanil wants to be analyzed, and the Ce_Remi + 
demographic data columns (age, height and weight) when the role of this information wants to be 
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studied. The last two cases imply a multiple logistic regression, while the propofol model is a simple 
logistic regression.  
One important aspect to consider is the fact that I choose Ce_Remi as covariable and not Cp_Remi. 
The reason for that is because Cp_remi shows an initial peak, called the plasma overshoot [55], 
which aims to generate the desired Ce at equilibrium and calculated from the rate constant for drug 
transfer intro the brain. This initial peak could introduce some error in the results. 
This rearrangement of the initial file is done to obtain a final result that enhances the probability to 
obtain a real BIS above 45 in the first half of the data (0<Pred_BIS<50 or Pred_BIS_disc= 0) and 
the probability to obtain a real BIS below 55 in the second half of the data (50<Pred_BIS<100 or 
Pred_BIS_disc=1).  
Ideally, the final result would be as depicted in Figure 9: prediction values of BIS between 45 and 
55 showing a probability of 1 to be in the optimal range. 
 
Figure 9: Schematic of the logistic regression model to be trained and evaluated. 
So, at the end, three models are performed, which lead to six logistic regressions; each model has 
two sub-models, depending whether the value of the predicted BIS is between 0 and 50 or 50 and 
100 which, at the same time, will depend on the initial concentration of propofol. 
As it is shown in Figure 9, the density of points of the data is really high in almost all the BIS range. 
As the optimal range only comprises 10 points of 100, if the model was trained with this original 
data it would lead to overfitting. So, the way to avoid this fact is eliminating data from the original 
file, so that in the case of model A the difference in the number of data between 0 and 45 and 45 
and 50 is not so high; and the same with the model B. To have an idea of this huge difference of 
points, there are 30636 points in model A and only 5184 range between 45 and 50. So, from these 
30636 values, only 9000 are maintained, and the rest are eliminated. The same occurs with the 
predicted BIS in model B: there are approximately 6000 values but only 1500 are in the optimal 
range (between 50 and 55). So, some rows are also eliminated to avoid the model mislabeling due 
to the overfitting. 
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Moreover, the set of dependent (y) and independent (x) variables are defined in this part. In all the 
cases, the dependent variables are the binary variables obtained from the real BIS columns: BIS > 
45 or BIS<55 in the model A and B, respectively, which, at the end, after joining model A and model 
B will represent the optimal depth of anesthesia range. The way of selecting the independent 
variables differs from the simple and the multiple logistic regression study. The simple case only 
has one independent variable, the Pred_BIS column, which is directly related with the propofol 
effect. However, the multiple models adds some columns: the Ce_Remi column in the second 
model and the Ce_Remi + age + height + weight columns in the third model. 
In order to summarize this preprocessing step and to understand the different columns contained 
by each file, Table 6 has been created: 
Model Data 































Table 6: Columns maintained after the preprocessing step. 
Finally, just before running the model, data has to be separated into two groups: training and testing 
set. This division is needed to evaluate the performance of the model and to assess how good the 
predictions are done. In this case, 75% of the data is randomly assigned to the training group and 
the 25% resting forms the testing group. This is done with a function from the Python package 




Once the data is processed, dichotomized and equilibrated to avoid overfitting, the model is built. 
In order to build the logistic regression models, Python offers many libraries; among others, the two 
most well-known libraries are StatsModels and Scikit-Learn. Although Scikit-Learn is popularly 
more related to ML and data science and StatsModels is matched with econometrics, generalized-
linear-models, timeseries-analysis and regression-models both of them are useful in this step. 
StatsModels is used to train the model, because it offers the possibility to generate multiple 
regression models, which are important when the effect of the covariables wants to be assessed. 
Furthermore, it reports the results in a more complete and understandable way. Moreover, Scikit-
Learn is useful when testing the model, because it offers a direct function to generate the ROC 
curves.  
5.3.1. Model	training	
The way of training the model is the same either in the simple logistic regression and in the multiple 
case. StatsModels provides a function which performs the logistic regression model: Logit(). But 
this library does not include the intercept β. by default, so the way to include it in the final results 
is by using the sm.add_constant() function. Then, the next step is fitting the model to the data with 
fit().  
Once the model is trained, StatsModels provides a detailed summary of the results with the 
summary() function. The output contains the number of “Iterations” that have been done over the 
data, in order to optimize the model and the results. By default, the maximum iterations that can be 
performed are 35; after this number, the optimization fails.  
Moreover, the summary includes two tables, one with the Logit Regression Results and another 
with the resulting coefficients of the model, its p-value and the corresponding confidence interval. 
From this second table, the most important parameters in which the attention will be focused are: 
- Coef: the value of the different coefficients of the dependent variables which conform 
logistic regression model. The const term refers to the intercept value. 
- P > |z|: this column shows the p-values for the different coefficients. If this value is above 
0.05, the predictor is considered “not statistically significant”. 
 The tables with the different results are included in the Appendix of the project. However, the 
summarized tables showing the results of the parameters obtained by the model and their 
significance are introduced in the tables below. 
Model A (propofol)  Model B (propofol) 
 Coefficient p-values Coefficient p-values 
β. -4.0704 0.000 5.0237 0.000 
[propofol] 0.0978 0.000 -0.0797 0.000 
Table 7: Logistic Regression parameters from propofol model. 
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First of all, the simplest model is analyzed. It considers only the effect introduced by the propofol 
concentration. Both parameters have a p-value highly low, which Python approximates to 0; they 
are depicted in Table 6. So, propofol can be considered to have an impact on predicting the optimal 
depth on anesthesia. 
From this first model, the two resulting equations describing the probability to be in the optimal 
depth of anesthesia range are: 
p(x) = log	(
1
1 + em(mn..p.n7...qpr·[eWZeZtZ^])) 
p(x) = log	(
1
1 + em(v..2wpm...pqp·[eWZeZtZ^])) 
Equation 13, 14: Probabilities to be in 45<BIS<50 and 50<BIS<55 for propofol model, 
respectively. 
Once the propofol effect is studied, a multiple logistic regression is done to analyze which effect is 
introduced by some covariables. Therefore, the second model built introduces this effect of the 
Remifentanil effect-site’s concentration. The results of the new parameters are depicted in Table 
8. As it is shown, propofol and remifentanil are good predictors as their p-value is below 0.05. 
 
In this case, the resulting probabilities to be in an optimal depth of anesthesia are described by 









Equation 15, 16: Probabilities to be in 45<BIS<50 and 50<BIS<55 for propofol+remifentanil 
model, respectively. 
Finally, the third model is the most complete one, which apart from studying the effect of Propofol 
and Remifentanil, introduces the effect of the demographic variables. The results of the parameters 
obtained with the training set are depicted in Table 9. One more time, all the variables are good 
Model A (propofol + remifentanil)  Model B (propofol + remifentanil) 
 Coefficient p-value Coefficient p-value 
β. -1.3748 0.000 4.4349 0.000 
[Propofol] 0.0655 0.000 -0.0865 0.000 
[Ce_Remi] -0.6491 0.000 1.1423 0.000 
Table 8: Logistic Regression parameters from propofol + remifentanil model. 
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predictors of the optimal depth of anesthesia as their p-values indicate they are statistically 
significant. 
 










Equation 17, 18: Probabilities to be in 45<BIS<50 and 50<BIS<55 for 
propofol+Remifentanil+Demographic variables model, respectively. Due to the lack of space, the 
parameters have been rounded to 2 digits. 
5.3.2. Model	testing	
The last part of the model is testing it. This stage uses the testing group that was previously set. 
This data has not been used to train the model, so it is useful to test it and assess its performance. 
The function used to test the model and predict new events is predict(). These predictions are 
obtained as values between 0 and 1; the nearer the result is to 1, the higher the probability to 
belong to the optimal range, in this case. The results are shown below.  
 
Model A (propofol + remifentanil + demographic 
variables)  
Model B (propofol + remifentanil + 
demographic variables) 
 Coefficient p-value Coefficient p-value 
β. -1.8748 0.008 -2.8895 0.175 
[Propofol] 0.0911 0.000 -0.0891 0.000 
[Ce_Remi] -0.6915 0.000 0.8551 0.000 
Age -0.0194 0.000 0.0380 0.000 
Height -0.0344 0.000 0.0310 0.012 
Weight 0.0949 0.000 0.0135 0.031 





Figure 10: Logistic Regression curve for the propofol model. 
  
 
Figure 11: Logistic Regression curve for the propofol + Ce_remi model. 
 
Figure 12: Logistic Regression curve for the propofol + Ce_remi + demographic variables model. 
 
From these graphs we can see how the dispersion around the mean decreases; so, adding these 
factors could improve the model. However, to confirm it, the model has to be evaluated; this is 




Once the model is tested, its performance has to be assessed. As introduced in Section 1.2.3.2, 
the best way of assessing the performance of the models is by evaluating the ROC curves. This is 
because the main goal of this study is not to classify the new events but to obtain a probability to 
be in the optimal depth of anesthesia, so we will not decide one threshold which leads to a unique 
classifier.  
So, as it has been done in the previous section, the different ROC curves are introduced following 
the order of the model to which they belong. Apart from the ROC curves, the results show the AUC-
ROC in the legend and the best threshold analyzed by the Python software in order to obtain the 
best accuracy for each model. However, this threshold is not reliable as we will set one or another 
depending on our objectives: decreasing sensitivity or specificity. 
The AUC-ROC for the propofol model are shown in the following figures and they have values of 
0.67 and 0.76 for Model A and Model B, respectively. These values are acceptable but the effect 
of the covariables must be studied in order to see whether they introduce an improvement in the 
predictions. 
 
Figure 13: ROC curves for propofol models. 
When the remifentanil effect is introduced, the ROC curves observed in figure 14 are obtained. It 
is observed how in both cases the area under these curves increases to 0.75 and 0.83 for models 
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A and B, respectively. So, remifentanil increases the predictive ability of the model and their values 
are more acceptable than in the previous case, where only the effect of propofol was considered. 
 
Figure 14: ROC curves for propofol + Remifentanil models. 
 
Finally, when the demographic covariables are added to the model, the AUC-ROC still increases 
to values of 0.84 and 0.80. These values are considered excellent so, at the end, the effect of all 




























This section covers the schedule of execution of the project. First of all, a work-breakdown structure 
(WBS) is shown: a hierarchic decomposition of the different tasks to fulfill during the project is 
introduced. It is useful in order to have a clear idea of the main tasks. Then, a GANTT diagram is 
depicted, which allows to have a clearer schedule of the tasks. 
6.1. Work-Breakdown	Structure	(WBS)	
As we can see, apart from the three tasks introduced in the detail engineering section, the project 
required a prior preparation to familiarize with the topic and, at the end, the report is written and the 
final presentation is carried out. 
 
Figure 16: WBS of the project 
 
6.2. GANTT	Diagram	
In order to generate the GANTT diagram from this WBS, Table 10 is needed. It shows the beginning 
and the end of each task. The data acquisition was thought to start at the end of January but, due 
to the third wave of Covid-19, this part finally started on February 18. The end of the model 
generation was on 27 April, when the supervisors approved the results and then the report was 





Activity Description Start date Duration (days) End date 
A Visit to CMA 21 dec 1 22 dec 
B Selection of the topic 2 feb 1 3 feb 
C Initial bibliographic research and 
reading 
3 feb 16 18 feb 
D Data acquisition of patients 
undergoing general anesthesia 
18 feb 34 24 march 
E Data processing to avoid overfitting 8 march 10 18 march 
F Elimination of the undesired columns 8 march 10 18 march 
G Transformation of some variables: 
dichotomization 
8 march 10 18 march 
H BIS prediction with Monolix 18 march 6 24 march 
I Model training 24 march 19 12 apr 
J Model testing 12 apr 2 14 apr 
K Model evaluation 14 apr 14 27 apr 
L Written report 27 apr 48 14 june 
M Power Point Presentation 14 june 7 21 june 
Table 10: Required tasks to accomplish the project objectives. 
Figure 17 shows the GANTT diagram. It gives an idea of the different tasks which were carried out, 
the data delimited to accomplish them and their respective duration. Furthermore, this diagram 
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The technical viability of the project refers to the technological characteristics involved in it. When 
talking about the technological aspects which are integrated in this project, we directly should think 
about the requirements of the different monitoring system devices and the software used during 
the programming step. However, the technical requirements of the monitoring systems used to feed 
the database are also introduced. 
7.1. Monitoring	systems’	requirements	
So, first of all the different technical requirements introduced by the use of the monitoring systems 
are commented below: [51, 55-57] 
- BIS VISTATM: This monitoring system includes the monitor (P/N 185-0151), a power cord, 
a pole clamp, a BISx (P/N 185-0145-AMS) and a PIC (Patient interface cable which 
connects BISx to patient). Apart from these components, the sensors are required.  
Moreover, the monitor must operate in the proper environment and if the limits are 
exceeded the results can be affected. These environment limits are a temperature between 
0 ºC and 40 ºC, a humidity between 15% and 95% and a pressure ranging from 360 mmHg 
to 800 mmHg.  
The system requires a power source of 100-240 VAC, 50-60 Hz and a maximum current 
consumption of 0.7 A. Furthermore, the monitor must be connected to ground to protect 
users and patients. 
The monitor contains a rechargeable lithium ion battery which lasts for 45 minutes when 
power cannot be supplied and the recharge time is about 6 hours. However, as most of 
the surgical procedures last from 30 minutes to 2 hours, it is advisable to charge the battery 
continuously by plugging it to the A/C power. 
The transfer of data can be done either by USB ports or by a RS-232 port.  
 
- Infinity® Gamma: The monitor is equipped with a color screen. The operating ranges are 
approximately the same than in BIS VISTA. 
The power supply requires a VAC from 100-120 for a current of 0.8A and a 200-240 VAC 
for a 0.4A supply. The frequency is the same as in the previous monitor: 50-60 Hz. 
Moreover, depending on whether the battery is made of lead-acid or lithium-ion it will have 
a capacity of 75 minutes or 210 minutes, respectively. And its charging time will be 5.5 
hours in the first case or 8 hours in the second case. 
 
- TCI-TIVA Orchestra®: The workstation is formed by a Orchestra® Base Primea and 2 
Orchestra® Module DPS. The power supply ranges from 95 to 240 V and 50-60 Hz and 
the battery has a minimum duration of 1 hour for the base and 5 hours for the module DPS.  
 
- Conox®: The available information of this device is reduced. The components that 
integrate this medical monitoring device are the Conox screen, a USB with legal 
documentation, power supply and cables, patient cables and Conox sensors. The battery 





The second part of the project consisted on processing the data by the use of software. So, the 
different softwares used during the project and their technical requirements for the proper 
functioning are described below: [58-61] 
- Python: The recommended hardware requirements to install Python are a modern 
operating system (Windows 7 or 10, Mac OS X 10.11 or higher, Linux RHEL 6/7), a 64-bit 
CPU (Intel /AMD architecture), 4GB of RAM and 5GB free of disk space. 
 
- Rugloop II®: The system requirements of this software are very limited. They only involve 
a personal computer, a processor Intel Penitum III (PIII), a personal memory card or USB 
and a Windows 2000 or Windows XP, at least. 
 
- Microsoft Excel: The system requirements are a Microsoft Windows 7 or later operating 
system, 1 Hz of processor speed, 1GB of minimum RAM size and 3GB of minimum Hard 
Drive Space. Moreover, a DVD-ROM and a DirectX 10.0 compatible graphic cards are 
required 
 
- MonolixSuite2020R1: Although I have not personally used this software, it is an important 
part of the results. It shows a 64-bits structure, the minimum operating system is Windows 
7 and 1 GB RAM or above is required. Moreover, a minimum screen resolution of 800x600 
pixels is recommended. 
7.3. SWOT	analysis	
These system requirements should be considered when developing the project. Once the project 
is developed, it is advisable to study its Strengths, Weaknesses, Opportunities and Threats (SWOT 
analysis). This analysis is helpful to identify the positive and negative aspects related to either the 
business competition and project planning and to create strategies to improve it. The SWOT 




















This section covers the different factors which suppose a cost during the project. The total cost of 
this project includes the salary of the people working on it, the computer with which the model has 
been done and the monitoring devices with which the database was fed.  
The project has been realized by me, an undergraduate coursing biomedical engineer. But during 
the development of the project I have been supervised by Dr. Gambús and Dr. Jaramillo, both of 
them anesthesiologists. So, the breakdown of the total costs of the project is depicted in Table 11. 
In this section, the costs will only consider the medical devices and the software needed to build 
the model. 
 Unity Price/unity Total 
 WORKERS’ SALARY 
Biomedical Engineer 300 hours 7€ /hour 2100 € 
Supervisors 30 hours 40€ /hour 1200 € 
 EQUIPMENT 
Asus F555L 1 700 € 700 € 
BIS VISTA monitor 1 4750 € 4750 € 
BIS VISTA electrodes 85 electrodes 
(1electrode/patient) 
15 € 1275 € 
 SOFTWARE LICENSES 
Python 1 Free 0 
Monolix 1 Free 0 
Microsoft 365 Personal 1 69 69 € 
Rugloop II 1 269 € 269 € 
TOTAL -  -  10363 € 







The development of this project involves some regulatory issues that have to be considered.  
During the acquisition of data, we are dealing with data from patients from which we have their 
consent to collect their data and treat with it. Although it is introduced anonymously in the database, 
their medical history is available from the moment the patient enters to the pre-operative room. 
That is why the “Ley Orgánica 3/2018” has to be accomplished. This legislation is called “Ley de 
protección de datos personales y garantía de los derechos digitales” [62] which, from the clinical 
perspectives has something to do in this project. Specifically, all the stuff that takes part in the 
treatment of this data has to ensure its confidentiality.  
The end product of this project is a Software as a Medical Device (SaMD). The Federal Food, Drug 
Administration (FDA) has made significant strides in the policies development for these products. 
SaMD are defined by the International Medical Device Regulators (IMDRF), the FDA’s benefit-risk 
framework, as “software intended to be used for one or more medical purposes that perform these 
purposes without being part of a hardware medical device.” [63] That is exactly what the Logistic 
Regression model intends; the medical purpose is assessing the probability of being in optimal 
depth of anesthesia, taking advantage of the results offered by the BIS VISTA, which would be the 
hardware. 
It is important to know which class would the product belong to if it was launched into the market. 
The Regulation (EU) 2017/745 of the European Parliament and the council on medical devices [69] 
classifies this SaMD as class IIb; it intends to monitor vital physiological parameters, whose 
variations could result in immediate danger to the patient. 
Once the SaMD product was validated and wanted to be commercialized, a marketing application 
should have to be submitted to FDA. This application should contain the submission type and data 
requirements based on the risk of this SaMD and if the permission was granted, the medical device 
could be distributed. If some later modifications were made to the design of the device, they should 
be reviewed under 510(k) notification. This notification software aims to assess if the changes 











Nowadays, basic and advanced monitoring systems are present in surgeries and they allow to have 
an idea of what is going on with the patient at every moment and if the injected doses of drugs can 
generate adverse effects. Moreover, they can indicate if some additional drug is needed in order to 
attenuate these effects. 
Being able to assess the probability to be in the optimal range of anesthesia from some input 
parameters can have a great impact in the surgical room. Furthermore, if this optimal effect is 
predicted in real time many adversities would be avoided. 
AI is gaining popularity in almost all the surrounding environments. However, it has not the order 
of the day yet in operating rooms. The aim of this project is to introduce the idea to include in them.  
The results show the efficiency of Logistic Regression to predict whether the optimal depth of 
anesthesia is achieved only considering propofol concentrations. Nonetheless, propofol is not 
enough to predict it, as the resulting ROC curves do not show excellent results. But as covariables 
are included, the values of the ROC curves increase, thus showing an improvement in the model. 
Specifically, when remifentanil and demographic variables are considered, the model has a higher 
predictive capability.  
Although the results show that the model is accurate, it could not be launched into the market yet. 
There are some limitations of the project and some aspects which would have to be studied before 
trying to approve it as a SaDM. 
First of all, it should be validated with external data, acquired after having built the model. This blink 
data would allow to evaluate better the performance of the model. Moreover, this model has been 
trained with a non-representative set of data; the whole database is formed by women so, future 
lines of this project could include men in the model and evaluating if the performance increases.   
Moreover, this project shows the probability to be in the optimal range. But something which could 
make the model more attractive would be adding the probability to be in an underdose and 
overdose stage, which would help even more the anesthesiologist. This could be done not by 
dichotomizing the real BIS variable as it has been done but creating three labels: 0, 1 or 2 if there 
is underdose, optimal depth of anesthesia or overdose, respectively.  
As explained in some sections above, the depth of anesthesia can be monitored by using other 
parameters apart from the BIS index. Introducing these parameters in the model, such as qCON, 
could lead to a better performance of the model as the number of variables directly related with the 
optimal level of anesthesia would increase, and so the data with which the model is trained and its 
performance.  
Leaving now the results and focusing on the total costs of this project, an approximation has been 
done in Section 6. However, it is not a fixed cost due to the price of BIS VISTA monitoring system; 
its price ranges from 4000€ to 5500€ [65] but sometimes the commercial company and the hospital 
reach an agreement and both of them take benefit from it. It could happen that the hospital wants 
to buy a new monitor and gives BIS monitors back to the company to make the supply more 
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attractive. Or sometimes the company is interested in getting rid of some sensors and gives the 
monitors for free or with a more affordable price. 
To conclude, it has been proved that the optimal level of anesthesia depends mainly on the quantity 
of injected drugs but also on the demographic variables, thus leading to an individualized attention, 
and AI could be introduced in the surgical environment as a tool to help both anesthesiologists and 
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The first step is predicting BIS with the Monolix software. The initial data contained in different files, 
one per patient, is reduced 10 times and is introduced in the same Excel file, which will be used by 
Dr. Jaramillo to generate the predictions. 
#Initial data is reduced 10 times: only 1 row each 10 is maintained. 
import os 
import pandas as pd 







for index in range(len(files)): 
    file= pd.read_excel("2.data_BIS/"+files[index], "Sheet1")  
 
    all_ind=[] 
    for element in range(len(file)): 
        all_ind.append(element) 
    ind_reduced=all_ind[0:len(all_ind):10] 
     
    a=file.iloc[ind_reduced,0]#id 
    b=file.iloc[ind_reduced,1]#time 
    c=file.iloc[ind_reduced,2]#bis 
    e=file.iloc[ind_reduced,4] #cp remi 
    f=file.iloc[ind_reduced,5] #ce remi 
    g=file.iloc[ind_reduced,6] #cp prop 
    h=file.iloc[ind_reduced,7] #ce prop 
    i=file.iloc[ind_reduced,8] #age 
    j=file.iloc[ind_reduced,9] #height 
    k=file.iloc[ind_reduced,10] #weight 
    l=file.iloc[ind_reduced,11] #gender 
    m=file.iloc[ind_reduced,12] #inf remi 
    l=file.iloc[ind_reduced,13] #inf propo 
 
    dat= {'ID_patient': a, 'Time(s)': b, 'BIS': c, 'CpREMI': e, 
'CeREMI': f, 'CpPROP': g, 'CePROP': h, 'age': i, 'height': j, 
'weight': k, 'gender': l, 'InfRateREMI': m, 'InfRatePROPO': l} 
    df=pd.DataFrame(data=dat) 














appended_data = [] 
for index in range(len(files)): 
    file= pd.read_excel("4.first_data/"+files[index], "Sheet1") 
    # store DataFrame in list 
    appended_data.append(file) 
appended_data = pd.concat(appended_data) 
# write DataFrame to an excel sheet  
appended_data.to_excel('appended_first_data.xlsx') 
 
Once the BIS predictions are generated, the files that will be used to build the model are created. 
First of all, two binary columns are created from the real BIS; depending on whether BIS<45 and 
BIS>45 or BIS<55 and BIS>55. Then, 6 files are created, for models A and B of the three cases 
studied (propofol, propofol + remifentanil and propofol + remifentanil + demographic variables). The 
dynamics followed in all the cases are the same, so only model 1A is commented on the code. 
import pandas as pd 
import numpy as np 
import os 
import numpy as np 
 
#we get the file with the BIS predictions (columns: id, time, bis, 
predicted_bis) 
path=r"C:\Users\jreyort\Desktop\Marta\TFG" 
file_pred= pd.read_excel("predictions.xlsx", "predictions") 
 






bis_45_100=[] #binary data for BIS<45 (0) and BIS>=45 (1), with 
respect to REAL BIS 
for value_1 in range(len(bis)): 
    if 0<bis[value_1]<=44.9: 
        bis_45_100.append(0) 
    elif 44.9<bis[value_1]<=100: 
        bis_45_100.append(1) 
    else: 
        bis_45_100.append(np.nan) 
 
bis_0_55=[] #binary data for BIS>55 (0) and BIS<=55 (1), with respect 
to REAL BIS 
for value_2 in range(len(bis)): 
    if 0<bis[value_2]<=54.9: 
        bis_0_55.append(1) 
    elif 54.9<bis[value_2]<=100: 
        bis_0_55.append(0) 
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    else: 
        bis_0_55.append(np.nan) 
 
pred_bis_disc=[] 
for value_3 in range(len(pred)): 
    if 0<=pred[value_3]<=50: 
        pred_bis_disc.append(0) 
    elif 50<pred[value_3]<=100: 
        pred_bis_disc.append(1) 
    else: 
        pred_bis_disc.append(np.nan) 
             
data_new= {'ID_patient': id_patient, 'Time(s)': time, 'BIS': bis, 
"BIS_up_45": bis_45_100, "BIS_down_55": bis_0_55, "Pred_BIS":pred, 
'Pred_BIS_disc': pred_bis_disc} 
df=pd.DataFrame(data=data_new) 
df.to_excel("data_model.xlsx", index = False, header=True) #the file 
is saved as an Excel 
 
#We now create and save the files we will use to build the multiple 
logistic regression models 
file_old= pd.read_excel("data_pacientes.xlsx", "Sheet1") 
file_model= pd.read_excel("data_model.xlsx", "Sheet1") 
 





pred_bis_disc=file_model.iloc[:,6] #no cal 
ce_remi=file_old.iloc[:,7] 
 
data_cp_remi= {'BIS': bis, "BIS_up_45": bis_45_100, "BIS_down_55": 
bis_0_55, "Pred_BIS":pred, 'Pred_BIS_disc': pred_bis_disc, "Ce_ReMI": 
ce_remi} 
df=pd.DataFrame(data=data_cp_remi) 
df.to_excel("data_model_cp_remi.xlsx", index = False, header=True) 
 











data_cp_remi_demo= {'BIS': bis, "BIS_up_45": bis_45_100, 
"BIS_down_55": bis_0_55, "Pred_BIS":pred, 'Pred_BIS_disc': 
pred_bis_disc, "Ce_ReMI": ce_remi, "Age": age, "Height": height, 
"Weight": weight} 
df=pd.DataFrame(data=data_cp_remi_demo) 









file= pd.read_excel("data_model.xlsx", "Sheet1") 
 
#selecting only the data from the model A (pred_bis<50) 
bis_50_down = file.loc[:, 'Pred_BIS_disc'] == 0 
df_bis_down = file.loc[bis_50_down] 
print("Longitud de los datos: ", len(df_bis_down)) 
 
#original data from model A saved to excel 
df_bis_down.to_excel("data_down50.xlsx", index = False, header=True) 
 
#originally, there are 30636 recordings but only 5184 are between 
45<pred_BIS<50 
file2= pd.read_excel("data_down50.xlsx", "Sheet1") 
bis1 = file2.loc[:, 'BIS_up_45'] == 1  
bis1_1 = file2.loc[bis1] 
 
#we reduce the data between 0<pred_BIS<45 to 9000, to balance it with 
the prior one related to the optimal level 
bis2 = file2.loc[:, 'BIS_up_45'] == 0 
bis2_2 = file2.loc[bis2] 
bis2_2.iloc[0:9000,:]  
 
#we concatenate the selected data, 0<pred_BIS<45 and 45<pred_BIS<50 
result = pd.concat([bis1_1, bis2_2.iloc[0:9000,:]]) 
 
#we shuffle the data 
result_shuffled=result.sample(frac=1).reset_index(drop=True) 
result_shuffled.to_excel("data_down50_new_model1.xlsx", index = False, 
header=True) 
 
#the resulting file is saved as an Excel 
file_new2= pd.read_excel("data_down50_new_model1.xlsx", "Sheet1")  
 
#------------------------------ 
#MODEL 1B, the same as in model A 
paths=r"C:\Users\jreyort\Desktop\Marta\TFG" 
file= pd.read_excel("data_model.xlsx", "Sheet1") 
 
#selecting only the data from the model B (pred_bis>50) 
bis_50_up = file.loc[:, 'Pred_BIS_disc'] == 1 
df_bis_up = file.loc[bis_50_up] 
print("Longitud de los datos: ", len(df_bis_up)) 
 
#original data from model B saved to excel 
df_bis_up.to_excel("data_up50.xlsx", index = False, header=True) 
 
#originally, there are 6118 recordings but only 1016 are between 
50<pred_BIS<55 
file2b= pd.read_excel("data_up50.xlsx", "Sheet1") 
bis1b = file2b.loc[:, 'BIS_down_55'] == 1  




#we reduce the data between 0<pred_BIS<45 to 9000, to balance it with 
the prior one related to the optimal level 
bis2b = file2b.loc[:, 'BIS_down_55'] == 0 
bis2_2b = file2b.loc[bis2b] 
bis2_2b.iloc[0:1016,:]  
 




result_shuffledb.to_excel("data_up50_new_model1.xlsx", index = False, 
header=True) 
 




#MODEL 2 (CE_REMI) 
paths=r"C:\Users\jreyort\Desktop\Marta\TFG" 
file_model2= pd.read_excel("data_model_cp_remi.xlsx", "Sheet1") 
 
#MODEL 2a 
bis_50_down_model2 = file_model2.loc[:, 'Pred_BIS_disc'] == 0  
df_bis_down_model2 = file_model2.loc[bis_50_down_model2] 
print("Longitud de los datos: ", len(df_bis_down_model2)) #30636 
recordings 
 
df_bis_down_model2.to_excel("data_down50_model2.xlsx", index = False, 
header=True) 
 
#the data is reduced to avoid overfitting. We eliminate only some data 
from the first part: 0<pred_bis<45 
file2_model= pd.read_excel("data_down50_model2.xlsx", "Sheet1") 
bis1_model2 = file2_model.loc[:, 'BIS_up_45'] == 1  
bis1_1_model2 = file2_model.loc[bis1_model2] 
len(bis1_1_model2) #5184 recordings in 45<pred_bis<50 
 
bis2_model2 = file2_model.loc[:, 'BIS_up_45'] == 0 
bis2_2_model2 = file2_model.loc[bis2_model2] 
bis2_2_model2.iloc[0:9000,:]  
 






#only the desired columns to build the model are selected; the rest 
are eliminated 
result_shuffled_model2.drop(['BIS', 'BIS_down_55', 'Pred_BIS_disc'], 
axis = 'columns', inplace=True) 
 
#the file is saved 







bis_50_up_model2 = file_model2.loc[:, 'Pred_BIS_disc'] == 1 
df_bis_up_model2 = file_model2.loc[bis_50_up_model2] 
print("Longitud de los datos: ", len(df_bis_up_model2)) #length: 6118 
 
df_bis_up_model2.to_excel("data_up50_model2.xlsx", index = False, 
header=True) 
 
file2_model= pd.read_excel("data_up50_model2.xlsx", "Sheet1") 
bis1_model2 = file2_model.loc[:, 'BIS_down_55'] == 1  
bis1_1_model2 = file2_model.loc[bis1_model2] 
len(bis1_1_model2) #only 1016 recordings are between 50<pred_bis<55, 
from 6118  
 
bis2_model2 = file2_model.loc[:, 'BIS_down_55'] == 0 
bis2_2_model2 = file2_model.loc[bis2_model2] 
bis2_2_model2.iloc[0:1016,:]   
 






#only the desired columns to build the model are selected 
result_shuffled_model2.drop(['BIS', 'BIS_up_45', 'Pred_BIS_disc'], 
axis = 'columns', inplace=True) 
 
result_shuffled_model2.to_excel("data_up50_new_model2.xlsx", index = 
False, header=True) 
 




#MODEL 3 (CE_REMI + DEMO) 
paths=r"C:\Users\jreyort\Desktop\Marta\TFG" 
file_model3= pd.read_excel("data_model_remi_demo.xlsx", "Sheet1") 
 
#MODEL 3a 
bis_50_down_model3 = file_model3.loc[:, 'Pred_BIS_disc'] == 0  
df_bis_down_model3 = file_model3.loc[bis_50_down_model3] 
print("Longitud de los datos: ", len(df_bis_down_model3)) 
 
df_bis_down_model3.to_excel("data_down50_model3.xlsx", index = False, 
header=True) 
 
file3_model= pd.read_excel("data_down50_model3.xlsx", "Sheet1") 
bis1_model3 = file3_model.loc[:, 'BIS_up_45'] == 1  
bis1_1_model3 = file3_model.loc[bis1_model3] 
 
bis2_model3 = file3_model.loc[:, 'BIS_up_45'] == 0 
bis2_2_model3 = file3_model.loc[bis2_model3] 
bis2_2_model3.iloc[0:9000,:]  
 









#we eliminate the undesired columns, leaving only the ones needed for 
the model 
result_shuffled_model3.drop(['BIS', 'BIS_down_55', 'Pred_BIS_disc'], 
axis = 'columns', inplace=True) 
 









file_model3= pd.read_excel("data_model_remi_demo.xlsx", "Sheet1") 
 
bis_50_up_model3 = file_model3.loc[:, 'Pred_BIS_disc'] == 1 
df_bis_up_model3 = file_model3.loc[bis_50_up_model3] 
 
df_bis_up_model3.to_excel("data_up50_model3.xlsx", index = False, 
header=True) 
 
file3_model= pd.read_excel("data_up50_model3.xlsx", "Sheet1") 
bis1_model3 = file3_model.loc[:, 'BIS_down_55'] == 1  
bis1_1_model3 = file3_model.loc[bis1_model3] 
 
bis2_model3 = file3_model.loc[:, 'BIS_down_55'] == 0 
bis2_2_model3 = file3_model.loc[bis2_model3] 
bis2_2_model3.iloc[0:1016,:] 
 






result_shuffled_model3.drop(['BIS', 'BIS_up_45', 'Pred_BIS_disc'], 
axis = 'columns', inplace=True) 
 
result_shuffled_model3.to_excel("data_up50_new_model3.xlsx", index = 
False, header=True) 
 
file_new1_model3= pd.read_excel("data_up50_new_model3.xlsx", "Sheet1") 
 
b. Model	building	
The last step is building the model. As in the previous section, the dynamics for building the model 
is pretty similar in all the cases, so only the first case is commented. 
#import libraries 
import pandas as pd 




import matplotlib.pyplot as plt 
import numpy as np 
from sklearn.model_selection import train_test_split 
import statsmodels.api as sm 
from sklearn.metrics import confusion_matrix, accuracy_score, 
roc_curve,auc, roc_auc_score 
 
#MODEL 1A PROPOFOL (pred_BIS<50) 
file_new_1b= pd.read_excel("data_down50_new_model1.xlsx", "Sheet1") 
 
#selecting dependent and independent variables 
X_1b = file_new_1b[["Pred_BIS"]] #pred bis < 50 
y_1b = file_new_1b['BIS_up_45'] #bis real>45 
 
#dividing data in test and train sets 
X_train_1b, X_test_1b, y_train_1b, y_test_1b = 
train_test_split(X_1b.values.reshape(-1,1), y_1b.values.reshape(-1,1), 




#building the model 
modelo_1b=sm.Logit(endog=y_train_1b, exog=X_train_1b,) 






X_test_1b = sm.add_constant(X_test_1b, prepend=True) 
predicciones_test_1b= modelo_1b.predict(exog = X_test_1b) 
plt.figure() 
plt.plot(X_test_1b,predicciones_test_1b,'.') 






fpr_1b, tpr_1b, threshold_1b = roc_curve(y_test_1b, 
predicciones_test_1b) 
auroc_1b = auc(fpr_1b, tpr_1b) 
gmeans_1b = np.sqrt(tpr_1b * (1-fpr_1b)) 
ix_1b = np.argmax(gmeans_1b) 
print('Best Threshold=%f, G-Mean=%.3f' % (threshold_1b[ix_1b], 
gmeans_1b[ix_1b])) 
plt.plot(fpr_1b, tpr_1b, 'b', label = 'AUC = %0.2f' % auroc_1b) 
plt.title('ROC (propofol model A)') 
plt.legend(loc = 'lower right') 




plt.xlabel('1 - Specificity') 









#MODEL 1B PROPOFOL (pred_BIS>50). Same steps as before 
file_new_1a= pd.read_excel("data_up50_new_model1.xlsx", "Sheet1") 
 
#selecting dependent and independent variables 
X_1a = file_new_1a[["Pred_BIS"]] #pred bis > 50 
y_1a = file_new_1a['BIS_down_55'] #bis real<55 
 
#dividing data in test and train sets 
X_train_1a, X_test_1a, y_train_1a, y_test_1a = 
train_test_split(X_1a.values.reshape(-1,1), y_1a.values.reshape(-1,1), 
train_size   = 0.75, shuffle= True, random_state=0) 
 







#model testing and validation 
X_test_1a = sm.add_constant(X_test_1a, prepend=True) 
predicciones_test_1a = modelo_1a.predict(exog = X_test_1a) 
fpr_1a, tpr_1a, threshold_1a = roc_curve(y_test_1a, 
predicciones_test_1a) 
auroc_1a = auc(fpr_1a, tpr_1a) 
gmeans_1a = np.sqrt(tpr_1a * (1-fpr_1a)) 
ix_1a = np.argmax(gmeans_1a) 
print('Best Threshold=%f, G-Mean=%.3f' % (threshold_1a[ix_1a], 
gmeans_1a[ix_1a])) 
plt.plot(fpr_1a, tpr_1a, 'b', label = 'AUC = %0.2f' % auroc_1a) 
plt.title('ROC (propofol model B)') 
plt.legend(loc = 'lower right') 




plt.xlabel('1 - Specificity') 
plt.scatter(fpr_1a[ix_1a], tpr_1a[ix_1a], marker='o', color='black', 
label='Best') 
plt.show() 











#MODEL 2A PROPOFOL + REMI (pred_BIS<50) 
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file_new_2b= pd.read_excel("data_down50_new_model2.xlsx", "Sheet1") 
 
#the variables of the model are selected 
X_2b = file_new_2b.drop(columns= "BIS_up_45") #pred bis < 50 + Ce_remi 
y_2b = file_new_2b['BIS_up_45'] #bis real>45 
 
X_train_2b, X_test_2b, y_train_2b, y_test_2b = train_test_split(X_2b, 








X_test_2b = sm.add_constant(X_test_2b, prepend=True) 
predicciones_test_2b = modelo_2b.predict(exog = X_test_2b) 
 
fpr_2b, tpr_2b, threshold_2b = roc_curve(y_test_2b, 
predicciones_test_2b) 
auroc_2b = auc(fpr_2b, tpr_2b) 
gmeans_2b = np.sqrt(tpr_2b * (1-fpr_2b)) 
ix_2b = np.argmax(gmeans_2b) 
print('Best Threshold=%f, G-Mean=%.3f' % (threshold_2b[ix_2b], 
gmeans_2b[ix_2b])) 
plt.plot(fpr_2b, tpr_2b, 'b', label = 'AUC = %0.2f' % auroc_2b) 
plt.title('ROC (propofol + remifentanil model A)') 
plt.legend(loc = 'lower right') 




plt.xlabel('1 - Specificity') 
plt.scatter(fpr_2b[ix_2b], tpr_2b[ix_2b], marker='o', color='black', 
label='Best') 
plt.show() 











#MODEL 2B PROPOFOL + REMI (pred_BIS>50) 
paths=r"C:\Users\jreyort\Desktop\Marta\TFG" 
file_new_2a= pd.read_excel("data_up50_new_model2.xlsx", "Sheet1") 
 
X_2a = file_new_2a.drop(columns= "BIS_down_55") #pred bis > 50 
y_2a = file_new_2a['BIS_down_55'] #bis real<55 
 
X_train_2a, X_test_2a, y_train_2a, y_test_2a = train_test_split(X_2a, 










X_test_2a = sm.add_constant(X_test_2a, prepend=True) 
predicciones_test_2a = modelo_2a.predict(exog = X_test_2a) 
fpr_2a, tpr_2a, threshold_2a = roc_curve(y_test_2a, 
predicciones_test_2a) 
auroc_2a = auc(fpr_2a, tpr_2a) 
gmeans_2a = np.sqrt(tpr_2a * (1-fpr_2a)) 
ix_2a = np.argmax(gmeans_2a) 
print('Best Threshold=%f, G-Mean=%.3f' % (threshold_2a[ix_2a], 
gmeans_2a[ix_2a])) 
 
plt.plot(fpr_2a, tpr_2a, 'b', label = 'AUC = %0.2f' % auroc_2a) 
plt.title('ROC (propofol + remifentanil model B)') 
plt.legend(loc = 'lower right') 




plt.xlabel('1 - Specificity') 














#MODEL 3A PROPOFOL + REMI + DEMOGRAPHIC VAR (pred_BIS<50) 
file_new_3b= pd.read_excel("data_down50_new_model3.xlsx", "Sheet1") 
 
X_3b = file_new_3b.drop(columns= "BIS_up_45") #pred bis < 50 + Ce_remi 
+ demographic data 
y_3b = file_new_3b['BIS_up_45'] #bis real>45 
 
X_train_3b, X_test_3b, y_train_3b, y_test_3b = train_test_split(X_3b, 








X_test_3b = sm.add_constant(X_test_3b, prepend=True) 




fpr_3b, tpr_3b, threshold_3b = roc_curve(y_test_3b, 
predicciones_test_3b) 
auroc_3b = auc(fpr_3b, tpr_3b) 
gmeans_3b = np.sqrt(tpr_3b * (1-fpr_3b)) 
ix_3b = np.argmax(gmeans_3b) 
print('Best Threshold=%f, G-Mean=%.3f' % (threshold_3b[ix_3b], 
gmeans_3b[ix_3b])) 
plt.plot(fpr_3b, tpr_3b, 'b', label = 'AUC = %0.2f' % auroc_3b) 
plt.title('ROC (propofol + remifentanil + demographic variables model 
A)') 
plt.legend(loc = 'lower right') 




plt.xlabel('1 - Specificity') 
plt.scatter(fpr_3b[ix_3b], tpr_3b[ix_3b], marker='o', color='black', 
label='Best') 
plt.show() 











#MODEL 3B PROPOFOL + REMI + DEMOGRAPHIC VAR (pred_BIS>50) 
file_new_3a= pd.read_excel("data_up50_new_model3.xlsx", "Sheet1") 
 
X_3a = file_new_3a.drop(columns= "BIS_down_55") #pred bis > 50 + 
ce_remi+ demographic data 
y_3a = file_new_3a['BIS_down_55'] #bis real<55 
 
X_train_3a, X_test_3a, y_train_3a, y_test_3a = train_test_split(X_3a, 








X_test_3a = sm.add_constant(X_test_3a, prepend=True) 
predicciones_test_3a = modelo_3a.predict(exog = X_test_3a) 
 
fpr_3a, tpr_3a, threshold_3a = roc_curve(y_test_3a, 
predicciones_test_3a) 
auroc_3a = auc(fpr_3a, tpr_3a) 
gmeans_3a = np.sqrt(tpr_3a * (1-fpr_3a)) 
ix_3a = np.argmax(gmeans_3a) 
print('Best Threshold=%f, G-Mean=%.3f' % (threshold_3a[ix_3a], 
gmeans_3a[ix_3a])) 
plt.plot(fpr_3a, tpr_3a, 'b', label = 'AUC = %0.2f' % auroc_3a) 
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plt.title('ROC (propofol + remifentanil + demographic variables model 
B)') 
plt.legend(loc = 'lower right') 




plt.xlabel('1 - Specificity') 
plt.scatter(fpr_3a[ix_3a], tpr_3a[ix_3a], marker='o', color='black', 
label='Best') 
plt.show() 












This second section shows the results obtained for each model. They were already introduced in 
the detail engineering but here appear in a more detailed way. 
Model A: propofol 
 






Model A: Propofol + remifentanil 
 
 




Model A: Propofol + remifentanil + demographic variables 
 
 
Model B: Propofol + remifentanil + demographic variables 
 
 
